TY - JOUR
T1 - The Glasgow prognostic score at diagnosis is an independent predictor of survival in advanced stage classical Hodgkin lymphoma
AU - Witte, Hanno
AU - Biersack, Harald
AU - Kopelke, Svenja
AU - Rades, Dirk
AU - Merz, Hartmut
AU - Bernard, Veronica
AU - Lehnert, Hendrik
AU - Fetscher, Sebastian
AU - Gebauer, Niklas
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers....
AB - Positron emission tomography (PET)‐guided strategies emerge as standard‐of‐care for advanced‐stage classical Hodgkin lymphoma (cHL) while conflict remains regarding early stage (I – IIa) disease and the necessity for treatment‐intensification among patients with a positive PET after two chemotherapy cycles (PET‐2) (Borchmann et al, 2017). Risk‐stratification remains crucial, increasing the requirement for predictive biomarkers....
UR - http://www.scopus.com/inward/record.url?scp=85047500783&partnerID=8YFLogxK
UR - http://www.mendeley.com/research/glasgow-prognostic-score-diagnosis-independent-predictor-survival-advanced-stage-classical-hodgkin-l
U2 - 10.1111/bjh.15198
DO - 10.1111/bjh.15198
M3 - Journal articles
C2 - 29785776
AN - SCOPUS:85047500783
SN - 0007-1048
VL - 184
SP - 869
EP - 873
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 5
ER -
